November 2022

MIMS Full Prescribing Update

New / Revised

Product Name

Section changed
New AKM Dabigatran
New APX-Ramipril
New Bella
New Bevaciptin
New Bromo-Biliaron
New Dimethyl Fumarate Sandoz
New Fyzant
New Iluvien
New Jynneos
New Lavione
New Metronidazole Tablets (Crescent) (Link)
New Mitocin
New Noumed Pregabalin
New Olanzapine Injection (Auromedics)
New Pemazyre
New Pharmacor Dabigatran
New Pomalidomide Sandoz
New Pomolide
New Rasagiline Sandoz
New Ropivacaine-AFT
New Sitagliptin/Metformin Sandoz
New Trecondi
New Vyxeos
Reinstated Isabelle
Reinstated Meropenem APOTEX
Revised Aciclovir GH Nature and Contents of Container, Pharmaceutical Form
Revised Adacel Shelf Life
Revised Agrylin Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Alphaclav Duo 500/125, Alphaclav Duo Forte 875/125 Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised APOC-5FU Cream TGA Date
Revised APO-Ciclosporin TGA Date
Revised APO-Clindamycin Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised APOHealth Promethazine Allergy Relief Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised APO-Hydroxychloroquine Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised APO-Ivabradine Adverse Effects (Undesirable Effects), Pharmacological Properties
Revised APX-Valaciclovir Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Atacand Plus Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Azacitidine MSN Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Benlysta Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Beovu Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Betahistine Viatris Fertility, Pregnancy and Lactation
Revised Bi Eligard cp TGA Date
Revised Bicard TGA Date
Revised Boostrix (preservative free) List of Excipients, Qualitative and Quantitative Composition, Special Precautions for Storage
Revised Bortezomib Juno Adverse Effects (Undesirable Effects), Pharmacological Properties
Revised Byetta Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Cefazolin-AFT 2 g Contraindications, Dose and Method of Administration, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Precautions for Storage, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Cefazolin-AFT 500 mg and 1 g Contraindications, Dose and Method of Administration, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Precautions for Storage, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Cefuroxime SXP TGA Date
Revised Chemists' Own Antihistamine for Allergy Relief Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Cimzia TGA Date
Revised Cinacalcet Viatris List of Excipients, Nature and Contents of Container, Product Name change
Revised Comirnaty Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Comirnaty (Tris/Sucrose Presentation) Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Nature and Contents of Container, New indication, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Shelf Life, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Cosentyx Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Cresemba Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Curam Duo 400/57 Powder for Suspension Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Curam Duo 500/125 and Curam Duo Forte 875/125 Tablets Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Darzalex SC Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Dasatinib ARX Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised DBL Amikacin Injection Special Warnings and Precautions for Use
Revised DBL Diazepam Injection Special Warnings and Precautions for Use
Revised DBL Gentamicin Injection BP Special Warnings and Precautions for Use
Revised DBL Irinotecan Injection Concentrate Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised DBL Phenytoin Injection BP Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised DBL Rocuronium Bromide Injection Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised DBL Tobramycin Injection BP Special Warnings and Precautions for Use
Revised DBL Vinblastine Injection Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Diabex List of Excipients, Nature and Contents of Container
Revised Diaformin List of Excipients, Nature and Contents of Container, Pharmaceutical Form
Revised Diaformin XR 1000 Nature and Contents of Container, Pharmaceutical Form
Revised Dithiazide Adverse Effects (Undesirable Effects), List of Excipients, Nature and Contents of Container, Special Warnings and Precautions for Use
Revised Dosulepin Viatris TGA Date
Revised Elelyso Dose and Method of Administration
Revised Emend IV Adverse Effects (Undesirable Effects)
Revised Estraderm MX Pharmaceutical Form, Qualitative and Quantitative Composition
Revised Feldene, Feldene-D Overdose
Revised Fenezine Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Fenocol Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Finnacar TGA Date
Revised Flubiclox Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use
Revised Fluticasone Salmeterol Ciphaler TGA Date
Revised Flutiform TGA Date
Revised Fragmin Dose and Method of Administration, Pharmacological Properties
Revised Gamunex Dose and Method of Administration, Nature and Contents of Container, Pharmacological Properties, Physicochemical Properties, Qualitative and Quantitative Composition
Revised Glyxambi Interactions with Other Medicines and Other Forms of Interactions
Revised Hequinel Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Hospira Levetiracetam Concentrate for IV Infusion Adverse Effects (Undesirable Effects)
Revised Hydrea Fertility, Pregnancy and Lactation
Revised Iclusig Adverse Effects (Undesirable Effects), Boxed Warnings, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Infanrix Hexa (thiomersal free) List of Excipients, Qualitative and Quantitative Composition
Revised Infanrix-IPV List of Excipients, Qualitative and Quantitative Composition
Revised Isobide MR TGA Date
Revised Jardiamet Interactions with Other Medicines and Other Forms of Interactions
Revised Jardiance Interactions with Other Medicines and Other Forms of Interactions
Revised Kenalog in Orabase TGA Date
Revised Keytruda Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties
Revised Lacosamide Lupin TGA Date
Revised Libtayo Adverse Effects (Undesirable Effects), Shelf Life
Revised Lynparza Tablets Adverse Effects (Undesirable Effects), Pharmacological Properties
Revised Maviret TGA Date
Revised Mayzent Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Mesalazine 1.2 TAKEDA Special Warnings and Precautions for Use
Revised Methotrexate Accord Adverse Effects (Undesirable Effects), Boxed Warnings, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use
Revised Mezavant Special Warnings and Precautions for Use
Revised Mizart Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Nature and Contents of Container, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Moxotens TGA Date
Revised Nerlynx Company Name change, TGA Date
Revised Neulasta Syringe with Automatic Needle Guard TGA Date
Revised Nevirapine Viatris Nature and Contents of Container, Product Name change
Revised Nimotop Nature and Contents of Container, Special Precautions for Storage
Revised Norditropin Dose and Method of Administration, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition
Revised Noumed Ciprofloxacin Adverse Effects (Undesirable Effects)
Revised Nyxoid Qualitative and Quantitative Composition
Revised Ondansetron Accord Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Otezla Sponsor
Revised Pegasys TGA Date
Revised Pfizer (Australia) Gentamicin Injection BP Contraindications, Special Warnings and Precautions for Use
Revised Pfizer (Australia) Metronidazole Adverse Effects (Undesirable Effects), New contraindication, Special Warnings and Precautions for Use
Revised Pfizer (Australia) Tobramycin Injection BP Special Warnings and Precautions for Use
Revised Pfizer (Australia) Tobramycin PF Special Warnings and Precautions for Use
Revised Pharmacor Linezolid Nature and Contents of Container, Special Warnings and Precautions for Use
Revised Pharmacor Zopiclone TGA Date
Revised Phenytoin Juno Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Qinlock Company Name change, TGA Date
Revised Qtern 5/10 Interactions with Other Medicines and Other Forms of Interactions
Revised Ralovista TGA Date
Revised Relpax TGA Date
Revised Renflexis Adverse Effects (Undesirable Effects)
Revised Ribomustin Adverse Effects (Undesirable Effects)
Revised Rinvoq Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, New indication, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Ruzurgi Sponsor, TGA Date
Revised Serc TGA Date
Revised Sertraline Sandoz Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use
Revised Sevelamer APOTEX TGA Date
Revised Spikevax Fertility, Pregnancy and Lactation, Pharmacological Properties
Revised Spiractin Interactions with Other Medicines and Other Forms of Interactions
Revised Spironolactone Viatris Interactions with Other Medicines and Other Forms of Interactions
Revised Spravato Adverse Effects (Undesirable Effects), Dose and Method of Administration
Revised Stildem TGA Date
Revised Tacrolimus Sandoz Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage
Revised Tecartus Adverse Effects (Undesirable Effects), Dose and Method of Administration, List of Excipients, New indication, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Telmisartan HCT GH Adverse Effects (Undesirable Effects), Deleted Presentation, Dose and Method of Administration, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Telmisartan Sandoz Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Telmisartan/HCT Sandoz Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Tenofovir Disoproxil Viatris Pharmaceutical Form, Product Name change
Revised Tezmota TGA Date
Revised Valtrex Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Vectavir Cream Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation
Revised Vimcosa Fertility, Pregnancy and Lactation
Revised Vitrakvi List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties
Revised Voltaren Rapid 12.5 Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Voltaren Rapid 25 Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Voriconazole APOTEX Powder for Injection Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Vzole Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Wagner Health Promethazine Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Xarelto Overdose, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Xgeva List of Excipients
Revised Xigduo XR Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Zavedos Pharmacological Properties, Special Warnings and Precautions for Use
Revised Zelitrex Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Special Warnings and Precautions for Use
Revised Zostavax List of Excipients
Deleted Abacavir/Lamivudine 600/300 APOTEX
Deleted Acarbose Viatris
Deleted Acpio
Deleted Addos XR
Deleted Alendro
Deleted Amcal Prochlorperazine
Deleted Amipride 400
Deleted Amoxycillin/Clavulanic Acid 500/125 Apotex
Deleted APO-Alendronate Plus D3 and Calcium
Deleted APO-Amoxycillin and Clavulanic Acid 875/125
Deleted APO-Cyproterone Acetate 100 mg
Deleted APO-Diazepam
Deleted APO-Gliclazide
Deleted APO-Lamotrigine
Deleted APO-Olanzapine
Deleted APO-Olmesartan
Deleted APO-Ondansetron ODT
Deleted APO-Pravastatin
Deleted APO-Primidone
Deleted APO-Prochlorperazine
Deleted APO-Raloxifene
Deleted APX-Ciprofloxacin
Deleted Aripiprazole Generichealth
Deleted Atripla
Deleted Aubagio
Deleted Ausran
Deleted BCG Vaccine SSI
Deleted BTC Perindopril
Deleted Camptosar
Deleted Candesartan GH
Deleted Candesartan HCT GH
Deleted Cannatrek T18 Flower Lemnos
Deleted Cefotaxime Sandoz
Deleted Celecoxib Apotex
Deleted Celecoxib BTC
Deleted Cisatracurium Injection (Kalcex)
Deleted Clindamyk
Deleted Co-Trimoxazole Paediatric Suspension (Aspen)
Deleted Diasp SR
Deleted Doxycycline AN
Deleted Enteclude
Deleted Famciclovir FBM
Deleted Famciclovir Generichealth
Deleted Famlo
Deleted Fenofibrate Lupin
Deleted Gabapentin APOTEX Capsules
Deleted Granisetron Sandoz
Deleted Inpler
Deleted Itracap
Deleted Karbesat
Deleted Kerron Tablets
Deleted Lercanidipine AN
Deleted Letrozole FBM
Deleted Lypralin
Deleted Maxatan
Deleted Maxydol
Deleted Melotin MR
Deleted Metformin XR APOTEX
Deleted Mirtazapine Sandoz ODT
Deleted Morphine MR Mylan
Deleted Moxicam Capsules
Deleted MycoCept
Deleted Paracetamol Generic Health
Deleted Pharmacor Cyproterone 100
Deleted Pharmacor Cyproterone 50
Deleted Pharmacy Care Prochlorperazine
Deleted Quetiapine GH
Deleted Rabeprazole-GA
Deleted Roxithromycin SCP
Deleted Sandoz Paracetamol Plus Codeine
Deleted Simvacor
Deleted Solicare (old formulation)
Deleted Sultiam-neuraxpharm
Deleted Terry White Chemists Telmisartan
Deleted Terry White Chemists Telmisartan HCTZ
Deleted Thiotepa for Injection, USP (Novadoz)
Deleted Trust Deworm
Deleted Ultiva
Deleted Urocit-K
Deleted Voriconazole APO

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au